BDBM350536 N-(4-bromophenyl)-2-[4-methyl-2,5- dioxo-4-(2-phenylethyl)imidazolidin- 1-yl]acetamide::US10208071, Table 3.12::US10799518, Structure TABLE 3.12

SMILES CC1(CCc2ccccc2)NC(=O)N(CC(=O)Nc2ccc(Br)cc2)C1=O

InChI Key InChIKey=OUBSCADNRKXOMJ-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 350536   

TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350536(N-(4-bromophenyl)-2-[4-methyl-2,5- dioxo-4-(2-phen...)
Affinity DataEC50:  860nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350536(N-(4-bromophenyl)-2-[4-methyl-2,5- dioxo-4-(2-phen...)
Affinity DataEC50:  8.60E+5nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent